Madison Mueller of Bloomberg News assesses that Novo Nordisk has been caught "flat-footed" by the rapid growth of the obesity drug market and is struggling to fill its product pipeline.

Access to obesity drugs for Medicare beneficiaries is scheduled to be expanded in July.

Eli Lilly became the first healthcare company to achieve a trillion-dollar market capitalization in the previous year.

The current Ebola virus strain circulating in the Democratic Republic of the Congo and Uganda has no known effective treatments or vaccines.

Eli Lilly hired former FDA official Peter Marks last year to lead its infectious diseases unit.

Eli Lilly's M&A strategy favors acquiring earlier-stage companies for cheaper deals over pursuing larger, later-stage mergers.

One of the companies being acquired by Eli Lilly is preparing to begin Phase 1 clinical trials.

Eli Lilly became the first healthcare company to achieve a $1 trillion market valuation last year.

Eli Lilly has a significant amount of cash on hand due to the commercial success of its blockbuster obesity and diabetes medications.

Eli Lilly hired former FDA official Peter Marks last year to lead its infectious disease unit.

Eli Lilly is pursuing acquisitions to build its next phase of growth in anticipation of its current blockbuster drugs losing patent protection.